JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.98, no.7, pp.1058-1061, 2006 (SCI-Expanded)
Objectives: To prospectively assess the efficacy and tolerability of bicalutamide monotherapy on biochemical failure of localized prostate cancer following total androgen deprivation (TAD) and 3D-conformal radiotherapy (3D-CRT).